Playback speed
10 seconds
Recent Clinical Trials in the Secondary Prevention of High-Risk PAD Patients: How Effective Are Rivaroxaban, Clopidogrel and Statins?
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Marc Bonaca
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Marc Bonaca
231 views
May 19, 2021
Comments 0
Login to view comments.
Click here to Login